Ultrastructural Lesions of Nodo-Paranodopathies in Peripheral Neuropathies.


Journal

Journal of neuropathology and experimental neurology
ISSN: 1554-6578
Titre abrégé: J Neuropathol Exp Neurol
Pays: England
ID NLM: 2985192R

Informations de publication

Date de publication:
01 03 2020
Historique:
received: 10 10 2019
revised: 05 11 2019
accepted: 05 12 2019
pubmed: 11 1 2020
medline: 22 7 2020
entrez: 11 1 2020
Statut: ppublish

Résumé

Whatever the cause of myelin damage of the peripheral nervous system, the initial attack on myelin by a dysimmune process may begin either at the internodal area or in the paranodal and nodal regions. The term "nodo-paranodopathy" was first applied to some "axonal Guillain-Barré syndrome" subtypes, then extended to cases classified as chronic inflammatory demyelinating polyradiculoneuropathy bearing IgG4 antibodies against paranodal axoglial proteins. In these cases, paranodal dissection develops in the absence of macrophage-induced demyelination. In contrast, the mechanisms of demyelination of other dysimmune neuropathies induced by macrophages are unexplained, as no antibodies have been identified in such cases. Electron microscopy of longitudinal sections of nerve biopsies is useful to visualize and authenticate the characteristic lesions of paranodes/nodes. However, it should be borne in mind that identical ultrastructural aspects are seen in other types of polyneuropathies: Genetic, experimental, and in a few polyneuropathies for which there is no obvious etiology. Ultrastructural nerve studies confirm the initial involvement of nodes/paranodes in various types of acquired and genetic neuropathies. For some of them, the antibodies or the proteins involved by mutations are clearly identified such as Caspr-1, Contactin-1, NFasc155, and NFasc186; other unidentified proteins are likely to be involved as well.

Identifiants

pubmed: 31923310
pii: 5700433
doi: 10.1093/jnen/nlz134
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-255

Informations de copyright

© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Auteurs

Jean-Michel Vallat (JM)

From the Department of Neurology, National Reference Center for 'Rare Peripheral Neuropathies', University Hospital, Limoges, France.

Laurent Magy (L)

From the Department of Neurology, National Reference Center for 'Rare Peripheral Neuropathies', University Hospital, Limoges, France.

Philippe Corcia (P)

Department of Neurology, ALS Reference Center, CHU Tours (Bretonneau Hospital), Tours, France.

Jean-Marc Boulesteix (JM)

Department of Neurology, Cahors Hospital, Cahors, France.

Antonino Uncini (A)

Department of Neurosciences, Imaging and Clinical Sciences, University "G. d'Annunzio", Chieti-Pescara, Italy.

Stéphane Mathis (S)

Department of Neurology, Nerve-Muscle Unit, CHU Bordeaux (Pellegrin University Hospital), Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH